Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119979) titled 'Comparison of Prognosis and Safety between Neoadjuvant Combined Surgery and Direct Surgery for Resectable HCC Patients in CNLC Stages ?b-?a, and Stratified Analysis of Neoadjuvant Strategies' on March 6.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Hepatocellular carcinoma
Intervention:
Neoadjuvant therapy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-07
Target Sample Size: Neoadjuvant therapy group:84;Surgery alone group:268; ...